<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04805775</url>
  </required_header>
  <id_info>
    <org_study_id>B076201420067</org_study_id>
    <nct_id>NCT04805775</nct_id>
  </id_info>
  <brief_title>Zhongnan Hospital of Wuhan University</brief_title>
  <acronym>ZhongnanH</acronym>
  <official_title>Zhongnan Hospital of Wuhan University</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhongnan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhongnan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the effects of desflurane and propofol anesthesia on sleep quality of breast&#xD;
      cancer patients after operation&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective to explore the relationship between anesthesia and postoperative sleep quality, and&#xD;
      to observe whether desflurane anesthesia is not inferior to propofol anesthesia in patients&#xD;
      undergoing elective radical mastectomy&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 15, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pittsburgh sleep quality index</measure>
    <time_frame>propofol group and desflurane group 1-3 days after operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh sleep quality index</measure>
    <time_frame>before operation, 4-7 days after operation and 1 month after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total sleep time (TST), rapid eye movement time (REM), wake-up time after sleep</measure>
    <time_frame>Before operation and within 1 week after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of functional connectivity (FC) and structural connectivity (SC) in resting state fMRI</measure>
    <time_frame>Before operation, 3 days after operation and 1 month after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression Scale score</measure>
    <time_frame>Preoperative, postoperative 1-7 days, postoperative 1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Desflurane</condition>
  <condition>Propofol</condition>
  <condition>Postoperative Sleep</condition>
  <condition>PSQI</condition>
  <condition>Mammary Cancer</condition>
  <arm_group>
    <arm_group_label>Desflurane Inhalant Product Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anesthesia maintenance: desflurane inhalation (mac1.0-1.2) sufentanil 0.3-0.5 μ g / (kg · h) atracurium CIS benzenesulfonate 1-3 μ g / (kg · min)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anesthesia maintenance: propofol TCI: 3-4ug / ml sufentanil 0.3-0.5 μ g / (kg · h) cisatracurium besylate 1-3 μ g / (kg · min)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane Inhalant Product</intervention_name>
    <description>Objective To observe the effect of desflurane on postoperative sleep quality of patients undergoing elective radical mastectomy. Methods 124 patients undergoing elective radical mastectomy were randomly divided into two groups: Propofol group and desflurane group</description>
    <arm_group_label>Desflurane Inhalant Product Group</arm_group_label>
    <arm_group_label>Propofol Group</arm_group_label>
    <other_name>Propofol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  （1）The operation time is 3-4 hours (2) Age 30-75 years old, BMI 18.5-25.0kg/m2, ASA&#xD;
             grade I or II (3) There was no depression (MDI &lt; 21) and cognitive impairment (MMSE ≥&#xD;
             27) before operation (4) Those who voluntarily participate in the research and sign&#xD;
             the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  (1) The patients received adjuvant chemotherapy before operation (2) At present, they&#xD;
             are taking psychoactive, opioid, anti anxiety and hypnotic drugs (3) Known or treated&#xD;
             patients with apnea syndrome (4) Patients with other cancers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 16, 2021</study_first_submitted>
  <study_first_submitted_qc>March 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2021</study_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

